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F
OR MORE THAU 100 years, bicarbonate administration has been considered the cornerstone of therapy for patients with severe acidemia associated with acute metabolic acidosis.l-j The administration of bicarbonate in this situation appeared logical because acute acidemia was shown to have a deleterious impact on organ f~n c t i o n . ' ,~-l~ It was assumed that bicarbon--ate administration would normalize extracellular pH, as well as intracellular (pHi). and restore organ function to normal. Results of several studies have suggested this thesis is overly simp l i s t i~.~~'~-'~ Thus. not only may acidemia per se be injurious. but its presence may induce adaptive processes that are not rapidly reversed or, paradoxically, themselves can be injurious to cell^.'^.'^ Moreover, bicarbonate administration under certain circumstances can have adverse consequences. 14,15. [19] [20] [21] [22] [23] [24] [25] In this review, we summarize the literature currently available concerning benefirs and complications of bicarbonate therapy in the treatment of the most common causes of severe acidemia observed clinically, with the hope that this information will assist clinicians in deciding on the value of bicarbonate (or another base! in these situations.
REQUIREMENT FOR THE REGULATION OF pH, AND EXTRACELLULAR pH
It has been postulated that cell pH is maintained at approximately 7.2 in the mammalian organism for several reasons: (1) to ensure that the large number of important metabolic intermediates are in the ionized state and therefore have little tendency to escape from the cell; (2) a large number of intracellular enzymes, such as phosphofructokinase (the rate-limiting enzyme of glycolysis), that take part in cellular metabolism have a pH optimum close to this value; and (3) DNA, RNA. and protein synthesis are hghly pH-dependent processes: and their synthesis is facilitated at this or a slightly higher PH."~;O pHi is maintained relatively constant by the activity of various plasma membrane hydrogenhase transporters, including the Naf/H' exchanger, H+-adenosine triphosphatase (ATPase). Na-HC03-cotransporter, C1--HCO? exchanger, sodium-dependent C1--HC03-xchanger, KA-HC03-cotransporter. and H',Kf -A T P~S~.~. '~-~' In response to acute acidemia, specific plasma membrane H'/HC03-transporkrs that return pHi toward its original value are activated. The nature of the transporters that primarily accomplish this task varies among different organ systems.
Maintenance of blood pH at approximately 7.4 is important to stabilize pHi at its normal value.".30 Regulation of extracellular pH independent of its effect on pH, might also be important. Thus. binding of some hormones to their receptors, such as insulin and catecholamines, is altered by changes in extracellular pH,32-34 and this effect might contribute to the adverse consequence of metabolic acidosis. Moreover, in some studies, acidemia had a negative impact on organ function without a detectable change in pHi. 35 Although normalization of pHi is important for proper cellular function, under certain conditions, some transport processes contributing to the normalization of pHi can paradoxically have adverse consequences on cellular function. One of the best characterized examples is the response of the heart to intracellular acidosis occurring in the setting of ischemia.I8 Several studies have shown that intracellular acidosis arising with ischemia increases the accivity of the Na--HT exchanger hXE1. Stiinulation of this antipcrter augments not only proton eff ux. but also sodium influx. The increased sodium is initially transported out of the cell through Na-,K'-ATPase to maincain a low intrltcellular sodium concentration. However, with continuing ischemia. the enhanced adenosine triphosphate (ATP) production necessary to support Na-,I<'-ATPase activity is constrained. Increased cell sodium concentrations decrease the activity of the Na'/Ca2' exchanger. thus increasing intracellular calcium l e~e l s . '~ Elevated inn-acellular calcium concentrations and low ATP levels can contribute to electrical instability of the myocardium and the generation of arrhythmias, cellular necrosis, and impaired myocardial function. Treatment with ethylisopropylarniloride, an inhibitor of the Na"-HA exchanger, has been shown to protect against cardiac ischemia and reperfusion and significantly reduce infarct size in various experimental modeis.I8 Theoretically. a similar sequence of events might occur in some types of metabolic acidosis if ATP generation by tissues is impaired in the presence of intracellular acidos i~, j~-'~ although t h s possibility remains to be examined.
IMPACT OF AClDEMlA ON CARDIAC FUNCTION
Severe acidemia is rarely lethal in the absence of cardiac dysfunction. Thus, complication-free survival has been observed in previously healthy individuals, even with severe lactic acidosis (blood pH < 6.8) after strenuous exer~ise.'~ In addition, patients with other causes of severe acidemia have survived blood pH values as low as 6.5,'5340.4' although the duration of exposure to the severe acidemia in these reports was limited. Conversely, severe acidemia can have profound effects on the function of various organs and contribute to increased morbidity and mortality. Although several organs are affected by severe acidemia, the impact on cardiac function is most critical to patient survival. Therefore, the majority of experimental and clinical studies have focused on the effect of acidemia on cardiovascular function. Major clinical sequelae of acidemia are listed in Table 1 . In 19 10, Jerusalem and Starling-" were among the first investigators to describe negative inotropic effects of acidemia associated with changes in Pco?. Subsequent in vitro studies using isolated cardiac muscle and heart preparations also showed a reduction in contractile force with exposure to an acidic milieu caused by a decrement of bicarbonate c~ncentration.'.~' To determine the level of pH at which alterations in cardiac function occurred. stepwise decrements of extracellular pH were produced by using either a bicarbonate-or non-bicarbonate-based solution.J3 Left ventricular pressure decreased slightly ( 5 4 to 10%) when extracellular pH was reduced from 7.4 to 7.2. However, there was a greater decrease (15%) if pH was reduced to levels less than 7.2. Conversely, if extracellular pH was reduced to 7.2 by increasing Pco? (acute respiratory acidosis). the decrease in left ventricular pressure was substantially greater (25% to 30%). Further reductions in extracellular pH to 6.7 caused left ventricular pressure to decrease by 30%. The decrement was greater when pH was decreased to the same degree by increasing PCO? (80%). The lesser impact of changes in extracellular pH with acute metabolic compared with acute respiratoty acidosis was also associated with a smaller decrease in pHi. Other in vitro studies confirmed the greater impact of acute respiratory compared with acute metabolic acidosis on cardiac function.
However, it should be noted that not all studies examining the impact of metabolic acidosis showed a decrease in myocardial pH. Studies performed in intact rats by Zahler et a1" and Bzttice et did not find a significant decrease in pHi in the myocardium during acute metabolic acidosis. Reasons for the differences among studies are not obvious.
. A similar correlation between the severity of acidemia and degree of cardiac depression was noted in whole animal experiments. In the intact animal. detectable depression of cardiac function was only apparent when blood pH was decreased to less than 7.2. 13 The contractile force of the left ventricle increased as blood pH was reduced from 7.4 to 7.2 and remained elevated as long as blood pH was not decreased further. The initial increase in cardiac contractile force appeared to be mediated in part by sympathoadrenal factors because blockade of adrenergic responses by pretreatment with propranolol abolished the positive inotropic response. Furthermore, there was a more precipitous decrease in cardiac output in animals administered propranolol when blood pH was decreased to less than 7.2.'7.J7 Decreases in cardiac output with some forms of acute metabolic acidosis may be even greater: cardiac output decreased by as inuch as 50% during lactic acidosis.",J8,-" The response of the heart to changes in extracellular pH is schematically shown in Fig 1. Thus, in vitro and in vivo studies have documented profound reductions in cardiac function when extracellular pH decreased to less than 7.2. Furthermore, it appears that a change in pHi is the most important factor determining the response of the heart to acute acidosis given that respiratory acidosis has a more profound impact on cardiac function than metabolic acidosis. However. a role for changes in extracellular pH per se cannot be excluded.
Cellular processes responsible for impairment of cardiac contractility during severe acidemia are incompletely understood. Several factors have been implicated, including an acidemia-related reduction in high-energy phosphate metabolic intermediates of the myocardial ell.''^^^ reduction or elevation in intracellular calcium leve l~, '~,~~ change in the availability of calcium for binding to troponin-myosin complex,52 or impairment of actin-myosin cross-bridge cycling by monovalent phosphate." 
Electrical Stability of the Myocardium
Experimental and clinical s t u d i e~j~.~~ have shown acidemia can contribute to the generation of cardiac arrhythmias in both the presence and absence of myocardial ischemia. Gerst et alj4 evaluated the ventricular fibrillation threshold in dogs made acidemic by reducing base concentration or increasing Pco:. Even minor reductions in blood pH to 7.3 associated with acute metabolic acidosis caused a decrease in the ventricular fibrillation threshold. The threshold was reduced further when blood pH was reduced to less than 7.1. Conversely, acidemia associated with acute respiratory acidosis had no impact on the ventricular fibrillation threshold, but produced abnormalities in myocardial repolarization in humans. indicating that it could predispose to arrhythmia development.j6 Examination of the relationship between acidemia and the appearance of arrhythmias in various clinical studies has not shown a strong orr relation.^' Arrhythmias were noted in some patients with severe acidemia, and in one study. post-myocardial infarction ventricular tachycardia and atrial fibrillation resolved after correction of acidernia.j5 Conversely. the presence of arrhyti.lmias in patients with myocardid infarction in a separate study was related more strongly to ihe presence of hypoperfusion. rather than the acidemia itself." Theoretically. individuals with cardiac disease should be more sensitive io the depressive and arrhythmogcnic effects of acidemia. but this possibility remains to be examined.
When arrhythmias develop, they are caused in part by a direct effect of acidemia on the heart to increase the diastolic depolarization rate.I9 Other factors that might contribute include alterations in serum and intracellular concentrations of calcium. magnesium, and potassium and the increased sympathetic discharge noted with acidosis, 9,19.58 Acidemia can have other deleterious effects on the myocardium. Using a cell-culture model, it was shown that a lower pH is important to the apoptotic cell death of myocardial cells in response to hypoxia or ischemia." Thus, apoptosis occurred in myocytes exposed to hypoxia only when extracellular pH was decreased, but not when a decrease in pH was prevented. Therefore. acidemia, if present. could potentially modify the extent of myocardial damage after coronary artery occlusion.
Peripheral Vascular Resistance
Acute metabolic acidosis causes a decrease in peripheral vascular resistance from a direct vasodilatory e f f e~t .~ However, because arterial vasoconstriction is enhanced by the increased sympathoadrenal dischargey noted with acute metabolic acidosis, the severity of the decrease in peripheral resistance will depend on the interplay of these countervailing forces. Patients administered P-blockers can have a more dramatic decrease in blood pressure because they lack some of the compensatory mechanisms required for adaptation to the decrease in peripheral resistance. The response of the vasculature to both aand P-adrenergic stimulation is also reduced in the presence of a low blood pH. theoretically m h n g patients with hypotension relatively resistant to pressors administered to increase blood pressure. The type of metabolic acidosis might have an impact on the resistance to administered agents. In an in vitro model of lactic acidosis, P-adrsnergic receptors were rapidly desensitized and uncoupled. Full expression of this effect required both an elevated lactate concentration and low pH (<?. l).j4
Although total peripheral vascular resistance decreases during acute metabolic acidosis, the response of the vasculature is not uniform in all vascular beds.9 For example, cerebral circulation is exquisitely sensitive to changes in blood pH. and metabolic and respiratory acidosis cause a decrease in cerebral vascular resistance and increase in cerebral blood flow.' Some experiments indicated that renal vascular resistance increased, whereas others showed dilatation of these vessels. Effects of acute metabolic acidosis on myocardial blood flow are complex because the acidemia accompanying metabolic acidosis can affect myocardial blood flow directly and possibly indirectly by altering myocardial oxygen c o n~u m p t i o n .~~ Both an increase and decrease in coronary blood flow have been observed during acute metabolic a c i d o~i s .~~.~' However, if alterations in blood flow to the heart and central nervous system are present. they might contribute in part to changes in cardiac and cerebral function observed with metabolic acidosis.
Low blood pH is also associated with venoconstriction9 caused by augmented sympathetic stimulation. This constriction of the venous system displaces blood into the central circulation, leading to elevated pulmonary vascular volume and pressure.
In summary, the acidemia that accompanies metabolic acidosis, if severe, alters cardiovascular function by suppressing myocardial contractility. potentially inducing arrhythmias, and decreasing total peripheral vascular resistance and blood pressure. The magnitude of the reduction in blood pressure also depends on the impact of catecholamines released during acute metabolic acidosis, which tend to favor vasoconstriction and increased cardiac output. Therefore, administration of P-blockers can modify the response to metabolic acidosis. Acidemia also produces venoconstriction, which, in combination with the depression of cardiac function, can predispose patients to the development of congestive heart failure.
Oxygen Delivery
Additional metabolic and physiochemical effects have been documented that alter the transport and delivery of oxygen to peripheral tissues independent of hemodynamic changes. ,4 decrease in pH reduces the affinity of hemoglobin for oxygen within minutes, thus enhancing the delivery of oxygen to tissues (Bohr effect). However, glycolysis is reduced over the ensuing 11. to 36 hours. thus depleting red blood cells of such important glycolytic intermediates as 2,3-diphosphoglyceric acid (DPG).h2.63 Because DPG decreases the affinity of hemoglobin for oxygen, reducing this moiety favors increased oxygen binding to hemoglobin. Thus, acute acidemia facilitates oxygen delivery, whereas more chronic acidemia hampers oxygen delivery. A chronically acidemic patient often has normal tissue oxygen delivery because of counterbalancing effects of these two processes. Rapid correction of chronic acidemia theoretically might impair oxygen delivery by suppressing the Bohr effect in the presence of low DPG levels.63
Electrolyte Abnormalities
Acute acidemia has complex effects on various serum electrolyte levels, which can modify the response of h e cardiovascular system during severe metabolic acidosis. An increase in serum potassium concentration can be observed during acidemia as a result of enhanced cellular potassium efflux. The increase in serum potassium concentration is more frequent with hyperchloremic acidosis and is often absent with organic acidoses, eg, acute lactic acidcsis in patients undergoing electroshock therapy.6%lthough metabolic acidosis initially is associated with a reduction in urinary excretion of potassium, it leads to an increment in kaliuresis as the acidosis is p r~l o n g e d .~~.~~ Thus, hypokalemia is frequently observed with acute metabolic acidosis. The serum potassium concentration found with metabolic acidosis depends on the interaction of these effects.
Changes in total and ionized calcium levels occur during acute metabolic acidosis as a consequence of several mechanisms. Ionized calcium level may increase immediately because of a pH-related decrease in the binding of free calcium to a l b~m i n .~~,~' Subsequently. total serum and ionized calcium levels might be altered by changing the concentrations andlor biological activities of vitamin D and parathyroid hormone. stimulating the release of calcium from bone. Processes that operate normally to correct acidernia in [he two types of metabolic acidosis, high anion gap and normal (hyperchloremic) anion gap, are listed in Table 2 . In high anion gap metabolic acidosis, with the exception of renal failure. the increase in the unmeasured anion gap is primwily caused by an increase in organic anion concentration^.^^^^^ After the metabolic abnormality producing the acidosis has been corrected, these anions are rapidly converted to bicarbonate in the tissues, as seen in the rapid restoration of plasma bicarbonate concentration after the cessation of strenuous exercise or discontinuation of electroshock therapy (disorders causing lactic Conversely, in normal anion gap metabolic acidosis. the concentration of chloride, a nonmetabolizable anion that cannot be convened to bicarbonate, is increased. Thus, rapid correction of metabolic acidosis by metabolic conversion of anions to bicarbonate cannot occur.
The second endogenous process that contributes to the normalization of serum bicarbonate concentrations in both high and normal anion gap metabolic acidosis is renal generation of new bicarbonate, primarily from a-ketoglutarate (derived from glutamine metabolism). Tnis process begins immediately, but may t&e several days to -.
reach its maximal rate. '' Because some disorders causing metabolic acidosis are associated with abnormal renal function. renal generation of new bicarbonate may be impaired. This is especially impofiant in normal anion gap metabolic acidosis, in which renal bicarbonate generation is the only endogenous mechanism available to correct systemic acidemia independent of administering exogenous bicarbonate.
Exogenous Bicarbonate Therapy: Benefits and Complications
The rationale given by some clinicians for the administration of sodium bicarbonate in patients with severe acidemia is that it increases arterial pH and pHi, thus eliminating potential adverse effects of acidemia on cardiac function. hepatic uptake of lactate. tissue perfusion, tissue oxygenation, and pHi.2.335 Conversely. the opposing view is that bicarbonate therapy should be withheld even in the treatment of patients with severe acidemia (blood pH < 7.1) because the administration of sodium bicarbonatc not only does not benefit the patient, but paradoxically, can lead to deterioration in systemic hemodynamics. in addition to producing volume overload, hyperosmolality. paradoxical cerebral spinal fluid (CSF) acidosis. increased organic acid production. and reduced pHi, 14-16. 22 .25.74
It should be emphasized that the controversy regarding the appropriateness of bicarbonate therapy in the treatment of severe acidemia has centered cn three clinical disease states: (1) type A lactic acidosis, (2) metabolic acidosis and hypercarbia associated with cardiac arrest. and ( 3 ) diabetic k e t o a c i d~s i s . '~~~'~ The majority of both experimental and clinical studies assessing the risks and benefits of bicarbonate therapy in the treatment of severe acidemia examined these three disorders. The emphasis on these thrse disorders undoubtedly occurs because collectively, they account for greater than 90% of patients with severe acidernia observed in the United States.:j Thus. we focus our anaiysis on these three disorders in evaluating the risks and benefits of bicarbonate therapy.
Diubetic Keroucidosis
In patients with diabetic ketoacidosis and hizh anion gap metabolic acidosis, rapid restoration of normal acid-base balance theoretically can be achieved by the administration of insulin and appropriate fluids. primarily as a consequence of the stoichiometric conversion of organic acid anions to bicarbonate. However. acidernia can contribute to insulin resistance, thus retarding the correction of ketoacidosis and hypergl ycemia and exposing the patient to adverse effects of these metabolic abnormalities for a longer Therefore. several studies were performed to determine whether bicarbonate therapy might ( 1 ) increase the rate of correction of acidemia and hyperglycemia, and ( 2 ) reduce morbidity and/or mortality in these patients. Animcrl st~1die.s. Few studies have addressed these issues in animals. Whittaker et a13? examined insulin sensitivity in rats with streptozotocininduced diabetes and ketoacidosis. Responsiveness to insulin was reduced in acidemic rats and directly correlated with blood pH. When blood pH was less than 6.9. there was little or no response. This effect was mimicked by acidemia produced by ammonium chloride administration. Moreover, correction of acidemia by bicarbonate administration reversed the insulin resistance.
Okuda et a174 assessed the effect of bicarbonaterich perfusate on hepatic production of ketones using an in situ liver preparation. Perfusate with this solution increased ketone production by the liver substantially. to twice the basal level. indicating that bicarbonate therapy stimulated ketone production by the liver, theoretically exacerbating ketoacidosis.
Beech et examined the response of rats with diabetic ketoacidosis that were anesthetized and placed on fixed ventilation. Rats were adrninistered saline. sodium bicarbonate, or Carbicarb, along with conventional insulin therapy. Treatment with either bicarbonate or Carbicarb caused a decrease in blood pressure, elevation in blood lactate concentration, and decrease in ratios of myocardial phosphocreatinine and .ATP to phosphate despite an increase in myocardial pH,, measured by nuclear magnetic resonance spectroscopy.
Studies of humans. Lever and J a~p a n '~ retrospectively compared recovery rates of plasma glucose and plasma bicarbonate concentrations. arterial pH, and level of consciousness in 52 patients with diabetic ketoacidosis treated with bicarbonate and 21 patients treated with only insulin, potassium, and saline (conventional therapy). Initial values for blood pH and plasma bicarbonate in the bicarbonate-treated group averaged 6.98 and 4.0 mEq/L and 6.96 and 3.5 inEq/L in the conventionally treated group. respectively. Mean changes in pH and plasma bicarbonate concentration (0.4 and I .0 mEq/L/h) were not different from those in the conventionally treated group (O.Cj6 and 1.3 mEq/L/h, respectively). Also, the rate of decrease in blood glucose level was not different. Most importantly, no mortality or increased morbidity occurred in the conventionally treated group. Hale et aIT8 compared [he benefit of jicarbonate therapy in patients with diabetic ketoacidosis and mild lactic acidosis randomly assigned to the administration of either bicarbonate or saline, along with insulin. Arterial pH increased more rapidly in patients administered bicarbonate; however. blood glucose levels decreased at the same rate with or without bicarbonate therapy. Also, there was a delay in decreases in both blood lactate concentration and lactate-pyruvate ratio in patients administered bicarbonate. No adverse effects were noted with bicarbonate treatment.
Assal et a179 evaluated bicarbonate therapy in 9 patients with severe diabetic ketoacidosis and impaired mental status. Bicarbonate therapy neither augmented the rate of decline in blood glucose levels nor decreased ketone levels in the blood. Morris et a180 evaluated 21 adults with severe diabetic ketoacidosis (blood pH, 6.9 to 7.14) randomly assigned to the administration of insulin with or without bicarbonate. During treatment, there was no difference between groups in rates of decline of blood glucose or ketone levels or increase of plasma bicarbonate or blood pH values.
Gamba et alY' studied 20 patients with severe ketoacidosis and plasma pH less than 7.15 (range, 6.9 to 7.14) in a double-blind randomized study. Patients were treated similarly except for the administration of bicarbonate or sodium chloride. Although plasma bicarbonate levels and pH increased more rapidly in the bicarbonate-treated group, there was no difference in the rate of return of blood glucose to normal levels. Furthermore, Pace?: Pao2, blood pressure. and mental status were similar in both groups. There were no deaths in either group. Viallon et alS2 evaluated the use of bicarbonate in patients with severe ketoacidosis; blood pH varied between 6.83 and 7.03. There was no si,@icant difference in recovery rates or complications between those administered bicarbonate and those administered conventional treatment. However, the group administered bicarbonate required greater quantities of potassium.
Okuda et a17%exsunined the recovery of hyperglycemia and resolution of ketonemia in three patients with severe ketoacidcsis (plasma pH, 6.95; plasma bicarbonate. 2.1 mEq/L) administered bicarbonate in addition to insulin and fluids and four patients with less severe disease (plasma pH. 7.27; plasma jicarbonate, 14.2 rnEq/L) administered insulin and fluids alone. Decrements in plasma glucose levels were similar in both groups. However, although the absolute and percentage increases in plasma pH and bicarbonate concentration were greater in the bicarbonatetreated group. plasma concentrations of ketone bodies actually rose. Conversely, plasma ketone levels decreased in the group administered insulin and fluids alone. These data indicate that rather than enhancing the rapidity of recovery of ketoacidosis, bicarbonate therapy might extend the period of ketoacidosis.
In one of the larger series. Green et a18' retrospectively examined the use of bicarbonate in 147 children with severe diabetic ketoacidosis. Fifty-seven children were treated without bicarbonate; 9 of these patients had blood pH values less than 7.00, and 1 patient had a pH of 6.73. Complications were similar between the groups. although the bicarbonate-treated group required a longer period of hospitalization.
In summary, although amelioration of acidemia with bicahonate therapy improves insulin sensitivity in studies of experimental animals. bicarbonate therapy in studies of humans (Table  3 i does not appear to speed the recovery from ketoacidosis or hyperglycemia or preven: complications in patients with diabetic ketoacidosis. Although studies in the literature do not support a role for bicarbonate in the treatment of diabetic ketoacidosis, it is important to recognize some of their limitations. These studies did not specifically evaluate patients with deficient endogenous mechanisms for the correction of acidemia, such as those with a low level of circulating rnetabolizable organic anions and patients with significant renal impairment, who potentially would be exposed to adverse effects of acidemia for a more prolonged time. Moreover, they also did not examine patients with significant cardiovascular disease, who might be more susceptible to the arrhythmogenic and depressive effects of acidemia. Further studies might be worthwhile to determine whether these groups of patients experience more complications during ketoacidosis, and if so, does bicarbonate therapy reduce the rate of complications. Potential morbidity of bicarbonate therapy. In addition to the lack of apparent benefit of bicarbonate therapy in diabetic ketoacidosis, complications of therapy have been described in patients with diabetes. In 1961, Posner and Plums4 reported the association between exacerbation of CSF acidosis and impaired brain function in patients with diabetic ketoacidosis administered bicarbonate. The investigators hypothesized that bicarbonate therapy suppressed ventilation; however, the administered bicarbonate did not easily cross the blood-brain barrier. Subsequent studies have shown the presence of similar CSF acidosis in patients administered insulin and saline, but not b i c a r b~n a t e . '~.~~ In nine patients with severe ketoacidosis and impaired mental status, blood pH increased from 7.06 ~r 0.03 to 7.41 5 0.04. whereas CSF pH paradoxically decreased from 7.27 + 0.0 1 to 7.15 2 0.03 within 4 hours after the administration of bicarbonate. Despite the decrease in CSF pH, mental status markedly improved in all patients. Moreover, in a group of similar patients administered only insulin and saline, a similar decrease in CSF pH was observed within hours of treatment.'9 Tnese studies confirm that some worsening of CSF acidosis is observed with treatment. but for the most part.
Exacerbation of hypokalemia also was rethese changes do not appear to have a clinical poned with bicarbonate therapy, but the clinical impact on the outcome of the patient.
relevance of this observation is unclear.3b Factors rezulating serum potassium concentration in diaberic ketoacidosis are complex (ie, changes in cranscellular potassium transport and altered renal potassi~m excretion). Bicarbonate therapy may unmas!c a potassium deficit caused by combined effects of osmotic diuresis and excrerion of nonreabsorbable ketone bodies on renal potassium excretion. The recognition that parients with diabetic ketoacidosis are usually significantly potassium depieted should readily allow for correction of potassium depletion with treatment. Volume expansion, with potential precipitation of congestive heart failure or exacerbation of hypertension, has been reported with the administration of sodium bicarbonate.' Volume expansion might also be a consequence of the sodium chloride routinely administered to these patients. However, the majority of patients have modest to severe volume deficits caused by vomiting or the osmotic luresis accompanying hyperglycemia. It therefore is less likely that substantial volume expansion will occur, and if it does. it can be managed easily by the administration of diuretics, or if severe renal impairment is present, the initiation of dialysis.
Hypernatremia and hypertonicity also have been reported with the administration of the typical hypertonic sodium bicarbonate ampules, which contain 4 4 mEq of sodium bicarbonate in 50 rnL of solution (880 rnEq/L).' This problem can be avoided by carefully following up serum sodium concentrations to detect the development of hypernatrernia and providing free water as needed.
Metabolic alkalosis (overshoot alkalemia) can result from excessive bicarbonate therapy because a patient with ketoacidosis has endogenous sources of bicarbonate (metabolic conversion of organic anions into bicarbonate with insulin therapy). The potential for this problem depends largely on the quantity of circulating organic acid anions. In some organic acidoses normally associated with a high anion gap. such as diabetic ketoacidosis, concentrations of circulating organic acid anions reflected by the delta serum anion gap may vary despite the presence of continued hypobicarbonatemia and a~i d e m i a .~~ A normal anion gap can occur at the time of presentation in volume-repleted patients or as a result of saline administration to patients with an initial high anion gap who are volume depleted. The serum sap in organic acidosis is determined not only by-the rate of organic acid anion generation, but aiso the rate of their renal excretion and conversion to bicarbonate. Ir, nonvciume-depleted patients with ketoacidosis. glomerular filtration rate is sufficiently preserved to allow enhanced renal organic anion excretion with sodium. favoring the development of a normal anion gap. In the presence of low levels of circulating ketone bodies, rapid generation of bicarbonate from the metabolism of ketone bodies is attenuated. As a consequence. these patients are at low risk for overshoot alkalosis. Conversely, they might also be subject to the adverse consequences of acidemia for a more prolonged period.
Cn the other hand. patients with hlgh circulating organic anior, levels are more prone to the development of overshoot alkalosis because of the dominance of endogenous mechanisms jie. metabolism of organic anions into bicarbon-
The rate of recovery from ketoacidosis is more rapid in patients with elevated organic acid anion levels than those with low organic acid anion levels.Y7 Calculation of the serum anion gap and cautious administration of base, taking into account these endogenous sources. will prevent significant alkalosis from occurring.
Finally, bicarbonate therapy can paradoxically increase the production of several organic acids, including acetoacetic acid, P-hydroxybutyric acid, and lactic a~i d . '~. " ,~~.~~ AS a consequence, bicarbonate therapy under certain circumstances might delay recovery from ketoacidosis or lactic acidosis. The mechanism underlying this effect has not been completely elucidated, but may be caused in part by intracellular alkalinization.
In summary. aithough bicarbonate therapy potentially can have such adverse consequences as volume expansion, hypernatremia. exacerbation of hypokalemia. development of overshoot metabolic alkalosis, and stimulation of organic acid production. most of these can be avoided by administering bicarbonate cautiously and carefully following up the patient's acid-base and electrolyte profiles. Studies of humans have not shown a significant negative impact of bicarbonate therapy on cardiovascular status. However, a single study by Beech et a16' in rats. cited previously, showed a negative impact of bicarbonate treatment. This result emphasizes the importance of designing additional studies of humans to sxamine the effect of bicarbonate therapy in patients with significant comorbid conditions.
Lactic Acidosis
TWO forms of lactic acidosis are klown. Type A lactic acidcsis is the most common form observed clinically and usually arises in the course of cardiac arrest, severe hypoxernia, or states of markedly impaired tissue perfusion. Type B lactic acidosis is less common and presents without overt clinical evidence of impaired perfusion. This type of lactic acidosis occurs primarily because of abnormal carbohydrate metabolism, eg, phenformin i n t o x i c a t i~n .~~.~~ Because acidemia was shown in experimental situations to reduce hepatic blood flow. theoretically impairing the clearance of lactate. and depress cardiac output, thus contributing to reduced tissue perfusion, it appeared logical to postulate that bicarbonate therapy would be beneficial in the treatment of lactic a c i d~s i s .~~j .~' Therefore. experimental studies performed in animals and clinical studies in humans were designed to determine whether bicarbonate therapy ( 1) facilitates recovery from lactic acidosis, (2) improves cardiovascular function, (3) affects lactate production, and (4) reduces mortality.
Animal studies (Table 4) . Arieff et a12' first developed several animal models of types A and B lactic acidosis to examine the effect of bicarbonate therapy on metabolic profile, cardiovascular status, and mortality of lactic acidosis. In one In another study from the same laboratory," a similar degree of lactic acidosis was produced in intubated anesthetized dogs by ventilation with a mixture of 8% oxygen and 92% nitrogen to simulate the hypoxic lactic acidosis observed in humans. Arterial PO-, was kept at 25 to 30 mm Hg, and arterial Pco-,, 35 mrn Hg. After lactic acidosis was established. animals were administered either isotonic fluid, 1 m o m of sodium bicarbonate at 2.5 mEq/kg of body weight per hour. or 1 m o m of sodium chloride at the same dosage. Decreases in arterial pH and plasma bicarbonate concentration, increments in gut lactate production, and increases in serum lactate levels were greatest in the bicarbonate-treated group. Moreover, sodium bicarbonate therapy also was associated with the greatest decrease in blood flow to the liver and gut and a decrease in liver pHi. Also, cardiac index and blood pressure declined significantly more in dogs administered bicarbonate than in those administered saline. No data for mortality were provided because the duration of observation was little more than an hour.
Halperin et a136 theorized that organ dysfunction in lactic acidosis arises primarily as the result of an inadequate rate of .ATP regeneration in viral organs. These investigators postulated that a large quantity of bicarbonate would have to be administered to maintain a normal &ITP regeneration rate and improve survival. They-" examined hemod!inamic profiles and survival times of rats with hypoxic L-lactic acidosis. a model similar to chat studied by ,keff' et al" in dogs. Rats were administered extremely large quantities of sodium bicarbonate (-12 mEqj to maintain plasma bicarbonate concentrations greater than 20 rnEq/L; no infusion; or an equivalent quantipj of sodium as chloride. As noted previously. cardiac output decreased dramatically (close to 50%) in animals administered bicarbcnate. However, cardiac output returned toward baseline values despite continuing bicarbonate administration after 20 to 30 minutes. In contrast to the studies of Arieff et al," survival was prolonged in animals administered bicarbonate (,50% survival at 50 minutes versus 5 0 4 survival at 20 minutes for the control group). Conversely, after more than 70 minutes had elapsed. the majority of animals administered bicarbonate also died. Therefore. bicarbonate therapy prolonged survival to only a limited degree. Results of this study are provocative. The quantity of bicarbonate administered is far in excess cf that currently recommended and presumably would be difficult to administer to patients with type A lactic acidosis, who usually have reduced renal function. However. bicarbonate could be administered while concomitantly removing fluid. either by administering diuretics or initiating dialysis. Moreover, dialysis also could serve as a vehicle to provide substantial quantities of bicarbonate. As discussed later, dialysis has been used with limited success in a small group of patients.
Other reports of lactic acidosis in animals also showed various adverse effects of bicarbonate. In a model of hemorrhagic shock. piglets administered bicarbonate with hemastarch had greater blood lactate levels, and tissue Po2 levels recovered slower than those in controls administered hemastarch alone.s9 Interestingly. bicarbonate administration did not depress cardiac output or blood pressure. Cooper et a190 measured hemodynamics and left ventricular mechanics in anesthetized atrially paced pigs with lactic acidosis induced by lactic acid infusion. Paco? was kept constant by adjusting ventilation. Bicarbonate administration reduced mean arterial pressure, but did not alter cardiac output. measured by the slope of the end-systolic pressure-volume relationship.
Ezech et al" examined the efkc't of bicarbonate administration cn hernodynamic status and skeletal muscle PI-! in rats with hypovolemic shock. There was no difference in skeletal muscle pH despite a significant increase in Pace: in the bicarbonate-treated group. Moreover, in contrast to other models of lactic acidosis, blood pressure increased with bicarbonate treatment to a similar degree as in saline-treated controls. Unfortunately, measurements of cardiac output or hemodynamic parameters were not obtained. Klepper et aIq2 examined the effect on hemodynamic parameters of administering 1 mol/L of sodium bicarbonate to dogs with hemorrhagic shock that were hypoxic and had mild hypercapnia (pH, 7.13: Paco?, 42.5 rnm Hg). Bicarbonate administration increased Pace: and pulmonary venous Pco?, but blood pressure and cardiac output both increased significantly.
In summary. many. but not all. reported studies of animals with hypoxic lactic acidosis administered bicarbonate showed a decrease in cardiac output. Concomitant with these hemodynamic alterations. venous Pco2 increased and pH, of the liver andlor myocardium decreased. Conversely. a decrease in cardiac output was not observed when bicarbonate was administered to animals with lactic acidosis caused by shock; cardiac Table 5 . Putative Factors Causing Decrease in Cardiac ou~put increased, presumably because of the accompanying volume expansion. Survival of animals with lactic acidosis administered bicarbonate has been examined in only two reported studies. Conditions of these studies differed dramatically, and the impact on survival was diametrically opposite: survival was unchanged in one study and prolonged in the other, although for a very short time. Further studies examining survival using different types of lactic acidosis are needed to determine the true impact of bicarbonate therapy on mortality.
As listed in Table 5 , several explanations have been proposed for the adverse effects of sodium bicarbonate administration on cardiac function, including a decrease in high-energy phosphare levels.35 decrease in intracellular pH,lJ reduction in blood ionized calcium level^,^^.^' and increase in intracellular calcium levels. 18 Zahler et a13j used the model of lactic acidosis produced by lactic acid infusion in rats to assess the impact of bicarbonate administration. Lactic acidosis produced in this fashlon led to decreases in blood pH and ratios of phosphocreatinine and ATF' to inorganic phosphate without a significant decrease in myocardial pHi. Subsequent bicarbonate administration for 30 minutes caused a further reduction in these ratios, but myocardial pH was not altered. Saline administration did not change these parameters. These investigators postulated that bicarbonate administration incedered with energy production, but not through changes in pHi. The precise mechanism was not determined. Numerous ir, vitro experiments using several different cell types have shown that the addition of bicarbonate to extracellular fluid can cause an increase in extracellular pH, but a decrease in pHi.93,9" The reduction in pHi occurs because the titration of bicarbonate by protons produces carbon dioxide and water. Because carbon dioxide permeates cellular membranes more rapidly than bicarbonate, intracellular carbonic acid concentration increases, transiently reducing pHi. Conversely. in these in vitro studies. if dissipation of carbon dioxide generated from bicarbonate administration is facilitated, the addition of bicarbonate leads to an increase in pHi.94 Similarly. even when large quantities of bicarbonate are administered to animals or humans with metabolic acidosis with well-preserved cardiovascular and pulmonary function. little change in Paco? occurs. However. in the presence of conditions that retard the rapid removal of carbon dioxide from tissues, such as hy?operfusion. an increase in tissue carbon dioxide level (best identified in mixed venous blood gases) and decrease in pHi 6ne decrease in pHi has been shown to occur in myocardium, brain, liver, skeletal muscle, and red blood A decrease in ionized calcium level is observed after extracellular pH is increased because this causes enhanced binding of free calcium to albumin.66 Studies by Cooper et a198 showed that the adrmnistration of bicarbonate to humans with lactic acidosis reduced ionized calcium levels by 10%. A decrease in ionized calcium levels produced by the administration of calcium binders or dialysis against a low calcium bath leads to marked reductions in cardiac contractility and cardiac output. whereas an increase in ionized calcium levels causes an increment in ~o n t r a c t i l i t y .~~.~~ The mechanism of this effect has not been completely elucidated. Thus: it is very likely that changes in ionized calcium levels could contribute to the myocardial depressive effects of bicarbonate administration.
Output in Response to Bicarbonate Administration
The administration of fluid with a pH greater than 7.4 during reperfusion of previously ischemic myocardium increases intracellular calcium level^.'^^'^^^^ Conversely, the increase in intracellular calcium levels is attenuated if the fluid is acidic. The explanation given for ths phenomenon is that reperfxsion with an alkaline fluid enhances cellular sodium influx through the plasma membrane Na'-H-exchanger at a time hen low intracellular ATP concentration results in inhibiiion cf cellular sodium efflux through NaL,K'-ATPase. The net effect is an increase in intracellular sodium concentration, which decreases the efflux of calcium through the plasma membrane Na+-Ca2+ exchanger, leading to an increase in invacellular calcium concentration. If ATP production is reduced in some forms of lactic acidosis, suggested by some investigat o r~:~~.~' it theoretically is possible that a similar sequence of events might be observed. This possibility remains to be examined.
Enhanced activity of the Na'-H' exchanger might have other consequences on the myocardial cell than just increasing intracellular calciuin concentration. Bicarbonate therapy has been proposed as a possible contributor to the development of cerebral edema in diabetic ketoacidosis." It was suggested that increased activity of the Na'-H' exchanger after bicarbonate administration increases intracellular sodium concenvation and causes swelling of cells. Support for a potentially important role for changes in intrace!-lular sodium levels after base administration comes from studies showing that improvement in cardiac function after the administration of Carbicarb to animals with metabolic acidosis was attenuated if cytosolic sodium concentration increased. lC0 Studies of humans. Although bicarbonate administration has been a mainstay of treatment of lactic acidosis for more than 50 years, surprisingly few clinical studies examining the impact of bicarbonate administration to patients with lactic acidosis have been published (Table 6) . Initial uncontrolled anecdotal reports or uncontrolled investigations showed little benefit from bicarbonate. Luft et all0' reviewed more than 300 cases of biguanide-induced lactic acidosis reported in the literature. Survival of patients administered bicarbonate was no better than in those treated with supportive care. Similarly, Stacpoole et allo2 reported 13 patients with hypotension-induced lactic acidosis eventually treated with dichloroacetate. Administration of up to 650 mmol of sodium bicarbonate did not substantially increase blood pH or improve hemodynamic situations. Conversely. Hilton et alloi examined the effect of bicarbonate-based hemoinitiation of treatment, respectively. Moreover, filtration in 177 patients with lactic acidosis seen lactic acidosis resolved in 45% of patients. alover 7 years. Although the mortality rate rethouzh half these patients eventually died. Simimained hlgh (71 %), in the majority of cases, lar resolution or marked improvement of metablood pH and plasma bicarbonate concentration bolic acidosis without hemodynamic compromise could be increased from means of 7.16 and 1 1.9 was reported in 2 patients with lactic acidosis rnEq/L to 7.41 and 24 mEq/L within 12 hours of 2nd sepsis treated by ultrafiltration and the admin-istration of !age quantities of bicarbonate. although both patients eventually died.'"" Fcur controlled studies examining the impact of sodium bicarbonate administration on iactic acidosis have been published. Cooper et alqY performed a randomized. blinded, crossover study of 14 patients with lactic acidosis (mean plasma bicarbonate. 17 mEy/L: mean plasma lactate. 7.8 mmol/L) in the intensive care unit. Thirteen of 14 patients required catecholamines to maintain blood pressure. Each patient sequentially was administered either sodium bicarbonate, 0.9 mol/L. at a rate of 2 mmolkg over 15 minutes, or an equivalent quantity of s o l u m chloride. Sodium bicarbonate infusion increased blood pH, bicarbonate concentration. and Paco, and reduced ionized calcium level. However, in contrast to hemodynamic effects observed in animal studies, cardiac output increased by 1840 and 16%, respectively, and pulmonary capillary wedge pressure increased to a similar degree with both solutions.
Bersin et allu5 examined the impact of sodium bicarbonate administration on cardiac hemodynamics, blood gas analysis results, lactate levels. and oxygen consumption in 10 patients with stable class 111 or IV congestive heart failure caused by ischemic cardiac disease and cardiomyopathy who had ejection fractions of 10% to 34% and presumed tissue hypoperfusion. Baseline plasma bicarbonate concentrations were 23 to 24 rnEq/L. and plasma lactate levels averaged 1.0 rnEq/L. Bicarbonate administration did not alter the mean cardiac output of the group: however, 2 of 10 patients experienced a large decrease in cardiac output of 25% to 50% with bicarbonate administration. Mean oxygen consumption and Pao? of the group decreased. whereas serum lactate levels increased slightly to 1.5 mEq/L.
Mark et allo6 studied 40 well-oxygenated patients undergoing major surgery who developed mild reductions in plasma bicarbonate concentrations intraoperatively (mean, 21 t 2 mEq/L). Half the patients were assigned to the administration of up to 58 mEq of sodium bicarbonate, and half were administered an equivalent quantity of saline as an intravenous bolus. Bicarbonate administration increased plasma bicarbonate concentrations from 2 1 to 25 mmol/L and Paco, from 41 to 44 mrn Hg. Cardiac output, ejection fraction. stroke volume, and blood pressure were noi statistically different from Saseline values in either g c u p .
Finally, Mathieu et aild7 studied I O critically ill patients ~. i t h lactic acidosis primarily caused by sepsis (8 of I0 patients). Patients were administered either 1 rnmolkg of sodium bicarbonate or an equivalent quantity of sodium chloride and observed for 60 rrinutes. With bicarbonate adrninistration. blood pH. plasma bicarbonate concentration. Paco,, and mixed venous blood Pcol increased. There was no effect of bicarbonate administration on serum lactate levels, cardiac output, blood pressure, or other hemodynamic variables.
In surnrnw, most patients treated with conventional doses of bicarbonate showed no increase in cardiac output or decrease in morbidity or mortality. However, those treated with large doses of bicarbonate and concomitant dialysis appeared to have a decrease in mortality. These studies, although limited in nature. could support the thesis of Halpenn et a1" that administration of large quantities of bicarbonate might prolong survival sufficiently to allow treatment of the underlying cause of lactic acidosis. Furthermore, depression of hemodynamic status with bicarbonate administration appears to occur only in a small subgroup of patients with mild acidosis and severe underlying cardiovascular disease. These results indicate that bicarbonate therapy might be more deleterious in patients with severe cardiovascular disease and show the need for further studies in this group of patients.
Cardiuc Arrest
Bicarbonate had been used for more than 30 years to treat acidemia accompanying cardiac arrest. Treatment with bicarbonate was believed to ameliorate acidemia, thus improving cardiac function. However. analysis of changes in blood and myocardial acid-base parameters during cardiac arrest showed that a decrease in myocardial pHi preceded a significant decrease in extracellular pH. Thus, after 5 minutes of cardiac arrest, although arterial pH was within normal range and mixed venous pH was 7.26, intramyocardial pH decreased from 7.2 to 6.9j.20-23 Moreover. within 2 minutes after the onset of cardiac arrest. cardiac venous PCO, increased from 40 to 165 mm Hg, and myocardial Pco,? to values exceeding 400 rnm Hg, with minimal changes in myo-cardial bicarbonate c o n~e n u a t i o n .~~ From these data. it was inferred that the dominant determinant of pH, with cardiac arrest is increased tissue carbon dioxide level, rather than a reduction in bicarbonate concentration. The increased tissue carbon dioxide level is a compcsite of both enhanced metabolic carbon dioxide production and reduced tissue removal of carbon dioxide caused by hypoperfusion.lo8 Thus, although reduced cardiac output can lead to lactic acidosis, this might not be the most important acid-base disorder affecting immediate survival. Data suggesting that: (1) the increase in myocardial carbon dioxide tension, by reducing pH,, has an important role in determining cardiac function; (2) bicarbonate administration can exacerbate the increase in myocardial carbon dioxide tenion'^,^^; and (3) bicarbonate administraticrr might provide little improvement in the success of cardiac r e s u s c i t a t i~n~~~~' :~ were some of the factors that contributed to abandoning the routine use of sodium bicarbonate for treatment of cardiac arrest. Presently, the American Heart Association recommends that bicarbonate not be routinely used in h e treatment of patients with cardiac arrest. l 7 Stildies of humans. Limited human studies have examined the benefits of bicarbonate therapy in cardiac arrest, with most published before 1990. Interestingly, Vukrnir et all1' analyzed all studies published before 1996 and founc! :hat six of nine studies showed some prolongation of survival time and two studies showed no effect. In a single study, outcome was worsened by bicarbonate administration. In this study, there was an inverse correlation between the amount of bicarbonate infused and s u r v i~a l , "~ ie. a negative effect on long-term survival was observed when more than 1 mEqkg was administered. Because most studies were uncontrolled, the efficacy of bicarbonate administration in these reports cannot be evaluated.
Animal studies. In contrast to the dearth of data in humans, a substantial number of studies were performed in animals to examine the utility of bicarbonate in the treatment of cardiac arrest. These studies analyzed various outcome measures. such as defibrillation success, survival, or neurological outcome. Importantly, it is worth noting that there were often subtle differences among the studies In such important factors as duration of cardiac arrest, tiining and dosage of buffer administration, and concomitant use of epinephrine or other measures affectin: tissue perfusion.
In general, those studies in which vasopressors were administered in addition to bicarbonate to improve cardiac perfusion pressure have shown the most benefit from bicarbonate administration. Vukmr et allL3 examined the impact of sodium bicarbonate on recovery from ventricular fibrillation-induced cardiac arrest for 5 or 15 minutes. The bicarbonate-treated group was administered 1 mmollkg initially, followed by continual administration to maintain plasma bicarbonate concentrations withln 5 mEqL of baseline, whereas the control group was administered lactated Ringer's solution. In addition, a high dose of epinephrine (0.1 mgkg) was administered to both groups. Minute ventilation was increased to maintain an end-ddal carbon dioxide level of 3.5% to 4.5%. A 60% increase in minute ventilation was necessary in the bicarbonate-treated group to reach this goal. Survival in the briefcardiac-arrest protocol t5 minutes) was similar in the presence and absence of bicarbonate administration, but it was greater in the prolonged-arrest group (15 minutes) administered bicarbonate. Moreover, neurological deficits after resuscitation were less in the bicarbonate-treated group. Of note, plasma pH was greater in the bicarbonate-treated group, but surprisingly, venous and arterial Pco2 were not different between the Bar-Joseph et allL4 studied the resuscitation of adult dogs subjected to cardiac arrest induced by ventricular fibrillation. Animals were treated with chest massage. epinephrine administration, and 1 mmollkg of sodium bicarbonate or 0.9% sodium chloride every 10 minutes for 40 minutes or until the return of spontaneous circulation. Of note, dogs were ventilated with a tidal volume of 15 rnLkg, fraction of inspired oxygen of 1.0, and frequency of 25 respirationslmin to induce slight hyperventilation. Bicarbonate-treated animals had greater coronary perfusion pressures and rates of resuscitation and shorter times to resuscitation compared with those administered sodium chloride (7 of 9 versus 2 of 10 dogs). Moreover, plasma bicarbonate and pH values increased to a greater degree in the bicarbonate-treated group than in animals administered saline. Pulmonary venous PCO: transiently increased after bicarbonate administration, but quickly returned to previous levels.
Redding and Pearsonl'j also showed that ths administration of sodium bicarbonate with epinephrine improved resuscitation from cardiac arrest. Conversely, Federiuk et al1I6 examined the resuscitation of swine subjected ro ventricular fibrillation for 15 to 20 minutes that were administered either epinephnne and bicarbonate or epinephnne and saline. Arterial and venous pH and venous Pco? were greater in the bicarbonate-treated group, but the success of defibrillation was similar between the groups. Guerci et alH7 examined recovery from ventricular fibrillation-induced cardiac arrest in dogs administered saline or bicarbonate 18 minutes after resuscitation had started. The administration of bicarbonate did not improve or impair the ability to defibrillate the animals despite an increase in mixed venous Pco?, Studies by Minuck and Sharma118 also found no benefit from bicarbonate compared with placebo in the success of resuscitation from cardiac arrest.
In summary, some studies showed an increased rate of resuscitation when bicarbonate was administered to animals with electrically induced cardiac arrest, whereas others showed no benefit. Those studies that showed an improved rate of resuscitation with bicarbonate administration shared common characteristics: in all studies, cardiac perfusion pressure was maintained by the administration of epinephrine. and in some studies, animals were hyperventilated to prevent the significant carbon dioxide accumulation associated with bicarbonate administration.
It is important to recognize some of the limitations of experiments evaluating bicarbonate therapy in the treatment of cardiac arrest. All studies described used animals in which the myocardium was healthy before the onset of cardiac arrest, and arrest was solely the consequence of venmcular fibrillation. It is more common in the clinical situation of cardiac arrest for patients to have some degree of heart disease, most commonly ischemic heart disease. In this regard. as noted previously, reperfusion of ischemic myocardium with a solution that has an elevated extracellular pH accentuates the increase in intracellular calcium levels and contributes to the e!ectrical instability genesis of 'mhyihmias and postischemic dysfunction.18 Funhe: studies are needed to examine the utility of bicarbonate in affecting the success of cardiac resuscitation. particularly in animals and individuals with underlying cardiac disease.
ALTERNATIVES TO BICAREONATE THERAPY
As described previously, bicarbonate administration often increases extracellular pH, but also increases carbon dioxide concentrations in blood and tissues. causing a transient decrease in pH, in several vital organs. including the heart.14.'2.9'
Because the decrease in pHi has been implicated as a factor important in the decrease in cardiac function observed after bicarbonate administration. investigators have focused on the development of agents that could increase both extracelIularpH and pHi. Two agents studied extensively are Carbicarb and tris-hydroxymethyl aminomethane (THAM).
Carbicarb
Carbicarb. a solution containing equimolar quantities of sodium bicarbonate and sodium carbonate, was first formuiated in 1983 by Filley and Kindig.'19 Ey virtue of its pK, it was postulated that sodium carbonate would be used as a buffer in preference to sodium bicarbonate. thus reducing or even obviating the generation of carbon dioxide and increasing extracellular pH without decreasing pH,. The discovery of this agent therefore initially generated a great deal of enthusiasm as a potential buffer effeclive in the treatment of metabolic acidosis.
Animal Studies
Initial studies performed in dogs with HCIinduced metabolic acidosis showed that 60 seconds after a bolus injection of Carbicarb. Pace?
and end-tidal carbon dioxide values increased minimally. whereas with sodium bicarbonate.
Pace? and end-tidal carbon dioxide values increased by 80%."9 Subsequent studies of rats120 with mixed metabolic and respiratory acidosis (pH 7.17) produced by asphyxia showed that the administration of sodium bicarbonate increased blood pH minimally (0.03 units) and markedly elevated both Paco-(19.1 mm Hg) and lactate concentration. Conversely. Carbicarb caused Paco, to increase by only 1.9 mm Hg and did not change lactate concentration. In an additiona! study. rats were made acidotic by feeding ammonium i-hloride or inducing hypercapnia. Administration of bicarbonatz to rats with metabolic acidosis resulted in an increase in Paco: and decrease in brain pH despite an increase in extracellular pH. Conversely. administration of Carbicarb caused an increase in extracellular pH and brain pH, without a change in P a~o~.~" Similarly. administration of Carbicarb to rats with ammonium chloride-induced metabolic acidosis led to an increase in blood pH, plasma bicarbonate concentration, and pH, of the liver without changes in cardiac output or blood pressure. Conversely, administration of bicarbonate led to a decrease in cardiac output and liver pHi.97
In a study of 28 dogs with hypoxic lactic a c i d~s i s , "~ Carbicarb administration led to an increase in extracellular pH and liver pH,, no change in mixed venous Pco7. improved lactate use by gut and liver, and stable cardiac output. Conversely, sodium bicarbonate administration led to deterioration in all these parameters. Similar results were obtained by Rhee et in mongrel dogs with hypoxic lactic acidosis. Carbicarb led to increases in extracellular pH, stroke volume index, and cardiac index without a change in serum lactate concentration. Again. bicarbonate administration led to an increase in Paco:, but no change in cardiac index. Surprisingly. myocardial pH, was not different with the administration of Carbicarb or bicarbonate.
Benjamin et allz4 compared the effects of Carbicarb. hypertonic saline, and sodium bicarbonate on cardiac index. blood pressure, and oxygen delivery in dogs with hemorrhagic shock. The administration of Carbicarb or sodium bicarbonate caused blood pH and bicarbonate concentrations to increase more than with saline. However, blood pressure. cardiac index. and oxygen dynamics increased to a similar extent in all three groups. Beech et al" compared the effects of Carbicarb, sodium bicarbonate, and sodium chloride on blood pressure, acid-base parameters, and pHi of skeletal muscle using nuclear magnetic resonance in rats with hypovolemic shock. Blood pH and bicarbonate concentration increased with either alkali. but there was no effect on pHi. Blood pressure increased equally in all groups. Similarly. Klepper et al" compared hemodynamic responses of dogs with hemorrhagic shock to bicarbonate or Carbicarb. Mixed venous carbon dioxide and Pace: increased significantly with bicarbonate administration. but was unchanged by Carbicarb. Cardiac output increased within minutes t~ an equal degree with both solutions.
Thus. in studies using models of ammonium chloride-induced metabolic acidosis or hypoxic lactic acidosis, the administration of Carbicarb. in contrast to bicarbonate, increased extracellular pH. pH,, and liver pHi and improved hemodynamics. Conversely, both bases had a similar effect on blood pH, bicarbonate concentration. and hemodynamics when administered to animals with either hypovolemia or hemorrhagic shock.
The value of Carbicarb compared with sodium bicarbonate in the treatment of cardiac arrest has been evaluated in several animal studies. Gazmuri et a 1~? 5 . ~? 6 showed that Carbicarb administration reduced blood Pcc:, whereas bicarbonate administration increased it. Both agents increased coronary blood pH and bicarbonate concentration. but did not alter coronacy vein Pco3 or change the success rate of res~~scitation from cardiac arrest of pigs. Conversely, Bar-Joseph et al"' examined the impact of Carbicarb compared with bicarbonate on hemodynamics and resuscitation after 10 minutes of cardiac arrest. These investigators showed that neither sodium bicarbonate nor Carbicarb altered arterial or mixed venous Pco?. Resuscitation was improved compared with controls, but was not different from the bicarbonate-treated group.
Kette et allz7 also compared Carbicarb with sodium bicarbonate in ventricular fibrillationinduced cardiac arrest in pigs. Three minutes after cardiac arrest, precordial compression was initiated, and Carbicarb or bicarbonate was administered. Defibrillation was instituted 11 minutes later. Carbicarb increased blood and cardiac venous pH, but decreased mixed venous Pco,: bicarbonate increased blood and cardiac venous pH, but also increased mixed venous Pco?. However, myocardial pH was not different in the presence or absence of either buffer, indicating that both buffers had little impact on intramyocardial acidosis. The number of animals resuscitated was slightly greater in the group administered Carbicarb compared with those administered bicarbonate, but was no different from the control group administered saline.
Studies examining potential benefits of Carbicarb in the treatment of cardiac arrest have snown equivocal results, with only a single study suggesting increased survival or enhanced resuscitation compared with bicarbonate. Thus. although there is a strong theoretical basis for beneficial effects of Carbicarb in the treatment of cardiac arrest, evidence to date is not convincing. Further studies are necessary to delineate the precise role for Carbicarb in the treatment of cardiac arrest.
Studies of Hurnuns
Only a single study has been published examining the use of Carbicarb in humans in the treatment of either lactic acidosis or cardiac arrest. Leung et studied the effect of Carbicarb compared with sodum bicarbonate on hemodynamics in well-oxygenated patients who developed mild metabolic acidosis during surgery. Carbicarb administration caused an increase in extracellular pH, but did not affect hemodynamic parameters of the group as a whole. However, in a small subset of patients. cardiac output increased by approximately 10% 60 minutes after treatment.
TH AM
THAM, a biologically inert amino alcohol, was first introduced as an in vitro titrating agent in 1946. In 1959, it was introduced into clinical medicine for the treatment of metabolic and respiratory acidosis. More than 2,200 articles have appeared in the medical literature concerning its use in various disorders, and there remains a group of individuals who champion its use for the treatment of these d i~0 r d e r s . I~~ The pK of THAM at 37°C is 7.8: therefore, it is a more effective buffer than bicarbonate in the physiological pH range. It penetrates cells easily and therefore is an effective intracellular buffer. In studies of dogs and rats with apneic hypercapnia, THAM was shown to reduce Paco2 leve l~. '~~. " ' In dogs with metabolic acidosis, the administration of THAW resulted in an increase in extracellular pH from 7.34 to 7.47, and in pH,, from 7.08 to 7.27.13' Importantly. despite producing a similar increase in plasma bicarbonate and blood pH values as bicarbonate, it reduced PCO? concentration of the CSF. Studies using a bloodperfused isolated heart preparation exposed to an acidemic milieu (pH 7.0) showed that the administration of THXM improved myocardial conaactility. whereas it was transiently worsened by bicarbonate administration. 'j2 Sun et all3' showed that global myocardial ischemia duiing cardiac arrest is often followed by myocardial dysfunction after successful resuscitation. which can contribute to increased mortality in the days after resuscitation. To determine whether THAM. Carbicarb, or bicarbonate might improve myocardial function and prolong survival after successful resuscitation, they examined the administration of these agents during cardiopulmonary resuscitation in rats with ventricular fibrillation. Carbicarb and THAM administration attenuated the postresuscitation decrease in myocardial pressure. prevented an increase in venous Pco?, and prolonged survival time far longer than the administration of bicarbonate.
In the treatment of septic shock, the administration of THAM was associated with less mortality than predicted. blood pH and bicarbonate values increased without increasing Pco?. It has been also used to maintain blood pH and ameliorate depressive effects of the increase in Pco3 on the myocardium in individuals on controlled hypercapnia.'3%lso, some older studies of diabetic ketoacidosis showed correction of metabolic acidosis and hyperglycemia without obvious Conversely. the intra-arterial infusion of THAM into coronary arteries of dogs with ischemic myocardium increased pH and bicarbonate concentration without increasing Pco~, whereas infusion of an equivalent amount of bicarbonate increased pH, bicarbonate concentration, and Pco?. However, there was no improvement in myocardial contractility in either Other uses of THAlM include treatment of elevated intracranial pressure after head injury and respiratory distress syndrome. Some of the interest in T H A I has been tempered by complications associated with its use. including respiratory depression, hypoglycemia, hypokalemia, venous irritation. and sclerosis.'30 As a result of these complications. THAM is rarely used for the treatment of pediatric disorders associated with metabolic acidosis or respiratory distress.
THAM remains an intriguing compound that might have some value in the treatment of severe metabolic acidosis and cardiac arrest and thus might be worthwhile reevaluating.
CONCLUSION
It is apparent from examination of the literature that normal acid-base balance is beneficial to the organism and acute severe acidemia potentially is deleterious. However, many studies have shown little or no benefit from rapid correction with bicarbonate of acidemia accompanying severe metabolic acidosis or cardiac arrest. As a consequence. in the past decade. the pendulum has swung in favor of those who would abandon the use of bicarbonate or other base therapy. A potential factor in the adoption of this global approach to treatment is the failure to recognize that patients with severe acidemia are not identical. It is important to stress that severe acidemia rarely occurs without the presence of comorbid conditions that can potentially modify not only the effect of acidemia on cellular and organ function. but also the response to bicarbonate or other forms of base. Therefore, relatively rapid correction of acidemia with base administration might be beneficial in some situations, but detrimental in others.
It is our contention that much research still remains to be done to further elucidate mechanisms by which acidemia affects organ function and examine the effect of bicarbonate or other base therapy on organ function, complication rates. and survival in the most frequent causes of severe acidernia: diabetic ketoacidosis, cardiac arrest. and lactic acidosis. Suggested potentially fruitful areas for future research include the following. ( 1 ) Examination of the impact of bicarbonate therapy or another base in the treatment of patients with significant underlying cardiovascular disease. This would be of great value because many patients with diabetic ketoacidosis, cardiac arrest, or lactic acidosis have underlying cardiovascular disease. (2) Exploration of the value of dialysis in conjunction with the administration of large quantities of bicarbonate in the treatment of lactic acidosis. These studies seem important because animal studies by Halperin et alJ9 and limited clinical studies of humans in whlch large quantities of bicarbonate were administered in conjunction with d i a l y s i~'~~. '~~ showed some improvement in survival. (3) Assessment of potential benefits on cardiovascular function of maintaining an elevated ionized calcium concentration constant during bicarbonate administration. This clinical srrategy might be valuabie in attenuating a deleterious effect of bicarbonate or other base on cardiac output. given the known positive correlation between ionized calcium and cardiovascular function. 14) Evaluation of a possible role for hyperventilation in ameliorating the depression of cardiac output caused by excess carbon dioxide production noted with bicarbonate therapy. Hyperventilation could be a valuable strategy in patients who are intubaied despite the reduced pulmonary blood flow often observed in patients with hypoperfusion. ( 5 ) Reexploration of a role for bicarbonate or alternative bases. such as THAM or Carbicarb. in the treatment of cardiac arrest. These studies seem necessary given that some animal studies showed increased rates of resuscitation under certain conditions. Results of the proposed studies should provide further information to allow the clinician to decide. when approaching patients with severe acidemic states, whether to treat cr not to treat with base.
